These rankings are based on data from September 2026
Company
GT Apeiron Therapeutics
Years in business
- 7
Number of employees
- 11-50 employees
Country
- United States
Apeiron Therapeutics is a clinical-stage biopharmaceutical company developing biomarker-driven, AI-enabled small molecule therapies for cancer. The company leverages structure-based, AI-driven drug design to build a pipeline of targeted treatments, aiming for best-in-class and first-in-class oncology candidates that address unmet medical needs.
API Availability
- Unknown
Pricing
unknown
Ranking position over time
October 2025 - September 2026
#3,468
Best rank
#9,274
Lowest rank
12-month trend
#14,911
Best rank
#19,058
Lowest rank
12-month trend
#1,229
Best rank
#1,899
Lowest rank
12-month trend
Position of GT Apeiron Therapeutics on sub rankings
September 2026
Industries
health & sports
research & development
Company
GT Apeiron Therapeutics
Years in business
- 7
Number of employees
- 11-50 employees
Country
- United States
- 5 New AI Tools: From the dentist's front desk to the law firm's intake
- Persona Development: The Most Popular AI Tools for Building Your Ideal Customer
- Behind the scenes: Better search, ranking history and faster tool listings
- 5 New AI Tools: From the AI crawler to the ChatGPT ad
- Erik Kaiser on wrappers, sovereignty, and why doing nothing is his biggest competitor
Insights
